| Literature DB >> 28648766 |
Chihiro Nishiura1, Akiko Nanri2, Ikuko Kashino2, Ai Hori3, Chihiro Kinugawa3, Motoki Endo4, Noritada Kato5, Aki Tomizawa6, Akihiko Uehara7, Makoto Yamamoto7, Tohru Nakagawa8, Shuichiro Yamamoto8, Toru Honda8, Teppei Imai9, Akiko Okino9, Toshiaki Miyamoto10, Naoko Sasaki11, Kentaro Tomita12, Satsue Nagahama13, Takeshi Kochi14, Masafumi Eguchi14, Hiroko Okazaki15, Taizo Murakami16, Chii Shimizu16, Makiko Shimizu16, Isamu Kabe14, Tetsuya Mizoue2, Tomofumi Sone17, Seitaro Dohi15.
Abstract
BACKGROUND: Long-term sick-leave is a major public health problem, but data on its incidence in Japan are scarce. We aimed to present reference data for long-term sick-leave among private sector employees in Japan.Entities:
Keywords: Incidence; Mental disorders; Neoplasms; Occupational health; Sick leave
Mesh:
Year: 2017 PMID: 28648766 PMCID: PMC5623020 DOI: 10.1016/j.je.2017.01.003
Source DB: PubMed Journal: J Epidemiol ISSN: 0917-5040 Impact factor: 3.211
Incidence rate of sick-leave among men in the J-ECOH cohort, 2012–2013.
| ICD-10 chapters | Number of spells during 2 years | Incidence rate of sick-leave (new spells/1000 person-years) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | Age categories, years | Overall | Age categories, years | |||||||||
| 20–29 | 30–39 | 40–49 | 50–59 | 60–64 | 20–29 | 30–39 | 40–49 | 50–59 | 60–64 | |||
| Overall | 1422 | 187 | 231 | 457 | 433 | 114 | 8.7 | 8.0 | 6.6 | 9.0 | 10.7 | 8.6 |
| Certain infectious and parasitic diseases (A00-B99) | 12 | 0 | 1 | 5 | 4 | 2 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 |
| Neoplasms (C00-D48) | 176 | 0 | 15 | 28 | 93 | 40 | 1.1 | 0.0 | 0.4 | 0.6 | 2.3 | 3.0 |
| Diseases of the blood and blood-forming organs and certain disorders (D50-89) | 1 | 0 | 0 | 0 | 1 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Endocrine, nutritional and metabolic diseases (E00-E90) | 20 | 0 | 1 | 7 | 7 | 5 | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | 0.4 |
| Mental and behavioural disorders (F00-F99) | 736 | 136 | 165 | 283 | 146 | 6 | 4.5 | 5.8 | 4.7 | 5.6 | 3.6 | 0.5 |
| Diseases of the nervous system (G00-G99) | 53 | 8 | 7 | 21 | 13 | 4 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.3 |
| Diseases of the eye and adnexa (H00-H59) | 16 | 2 | 3 | 3 | 5 | 3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 |
| Diseases of the ear and mastoid process (H60-95) | 4 | 0 | 0 | 3 | 0 | 1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 |
| Diseases of the circulatory system (I00-I99) | 104 | 2 | 2 | 27 | 58 | 15 | 0.6 | 0.1 | 0.1 | 0.5 | 1.4 | 1.1 |
| Diseases of the respiratory system (J00-J99) | 16 | 2 | 3 | 4 | 6 | 1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Diseases of the digestive system (K00-K93) | 38 | 2 | 6 | 7 | 17 | 6 | 0.2 | 0.1 | 0.2 | 0.1 | 0.4 | 0.5 |
| Diseases of the skin and subcutaneous tissue (L00-L99) | 5 | 1 | 2 | 1 | 0 | 1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 |
| Diseases of the musculoskeletal system and connective tissue (M00-M99) | 102 | 10 | 10 | 29 | 41 | 12 | 0.6 | 0.4 | 0.3 | 0.6 | 1.0 | 0.9 |
| Diseases of the genitourinary system (N00-N99) | 7 | 1 | 1 | 2 | 2 | 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) | 2 | 0 | 0 | 1 | 1 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99) | 7 | 1 | 0 | 4 | 2 | 0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| Injury, poisoning and certain other consequences of external causes (S00-T98) | 118 | 22 | 14 | 30 | 36 | 16 | 0.7 | 0.9 | 0.4 | 0.6 | 0.9 | 1.2 |
| Factors influencing health status and contact with health services | 4 | 0 | 1 | 1 | 1 | 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| N/A | 1 | 0 | 0 | 1 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Risk time (person-years) | 162,989 | 23,488 | 35,070 | 50,813 | 40,379 | 13,240 | ||||||
N/A, no applicable ICD-10 code for the medically certified diagnosis.
Categories were omitted when there was no case.
Incidence rate of sick-leave among women in the J-ECOH cohort, 2012–2013.
| ICD-10 chapters | Number of spells during 2 years | Incidence rate of sick-leave (new spells/1000 person-years) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | Age categories, years | Overall | Age categories, years | |||||||||
| 20–29 | 30–39 | 40–49 | 50–59 | 60–64 | 20–29 | 30–39 | 40–49 | 50–59 | 60–64 | |||
| Overall | 289 | 52 | 84 | 93 | 48 | 12 | 9.4 | 11.3 | 11.1 | 8.9 | 7.7 | 6.5 |
| Certain infectious and parasitic diseases (A00-B99) | 1 | 0 | 0 | 0 | 1 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 |
| Neoplasms (C00-D48) | 58 | 3 | 7 | 25 | 16 | 7 | 1.9 | 0.7 | 0.9 | 2.4 | 2.6 | 3.8 |
| Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-89) | 1 | 0 | 0 | 1 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| Endocrine, nutritional and metabolic diseases (E00-E90) | 2 | 0 | 1 | 0 | 1 | 0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.2 | 0.0 |
| Mental and behavioural disorders (F00-F99) | 101 | 30 | 29 | 35 | 7 | 0 | 3.3 | 6.5 | 3.8 | 3.4 | 1.1 | 0.0 |
| Diseases of the nervous system (G00-G99) | 6 | 2 | 2 | 1 | 1 | 0 | 0.2 | 0.4 | 0.3 | 0.1 | 0.2 | 0.0 |
| Diseases of the eye and adnexa (H00-H59) | 3 | 0 | 0 | 0 | 2 | 1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.3 | 0.5 |
| Diseases of the ear and mastoid process (H60-95) | 2 | 1 | 1 | 0 | 0 | 0 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 |
| Diseases of the circulatory system (I00-I99) | 8 | 0 | 1 | 4 | 2 | 1 | 0.3 | 0.0 | 0.1 | 0.4 | 0.3 | 0.5 |
| Diseases of the respiratory system (J00-J99) | 3 | 0 | 1 | 0 | 2 | 0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.3 | 0.0 |
| Diseases of the digestive system (K00-K93) | 9 | 0 | 3 | 3 | 2 | 1 | 0.3 | 0.0 | 0.4 | 0.3 | 0.3 | 0.5 |
| Diseases of the skin and subcutaneous tissue (L00-L99) | 2 | 1 | 0 | 0 | 1 | 0 | 0.1 | 0.2 | 0.0 | 0.0 | 0.2 | 0.0 |
| Diseases of the musculoskeletal system and connective tissue (M00-M99) | 21 | 1 | 4 | 9 | 6 | 1 | 0.7 | 0.2 | 0.5 | 0.9 | 1.0 | 0.5 |
| Diseases of the genitourinary system (N00-N99) | 2 | 1 | 0 | 1 | 0 | 0 | 0.1 | 0.2 | 0.0 | 0.1 | 0.0 | 0.0 |
| Pregnancy, childbirth and the puerperium (O00-O99) | 41 | 10 | 27 | 4 | 0 | 0 | 1.3 | 2.2 | 3.6 | 0.4 | 0.0 | 0.0 |
| Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) | 1 | 0 | 0 | 0 | 1 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 |
| Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99) | 1 | 0 | 0 | 1 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| Injury, poisoning and certain other consequences of external causes (S00-T98) | 27 | 3 | 8 | 9 | 6 | 1 | 0.9 | 0.7 | 1.1 | 0.9 | 1.0 | 0.5 |
| Risk time (person-years) | 30,645 | 4615 | 7570 | 10,419 | 6201 | 1840 | ||||||
Categories were omitted when there was no case.
Incidence rate of sick-leave due to neoplasms or mental and behavioural disorders among men in the J-ECOH cohort, 2012–2013.
| ICD-10 chapters and blocks | Number of spells during 2 years | Incidence rate of sick-leave (new spells/1000 person-years) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | Age categories, years | Overall | Age categories, years | |||||||||
| 20–29 | 30–39 | 40–49 | 50–59 | 60–64 | 20–29 | 30–39 | 40–49 | 50–59 | 60–64 | |||
| Neoplasms (C00-D48) | 176 | 0 | 15 | 28 | 93 | 40 | 1.1 | 0.0 | 0.4 | 0.6 | 2.3 | 3.0 |
| Malignant neoplasms (C00-C97) | 156 | 0 | 9 | 23 | 88 | 36 | 1.0 | 0.0 | 0.3 | 0.5 | 2.2 | 2.7 |
| Malignant neoplasms of lip, oral cavity and pharynx (C00-C14) | 8 | 0 | 0 | 2 | 3 | 3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 |
| Malignant neoplasms of digestive organs (C15-C26) | 78 | 0 | 3 | 10 | 50 | 15 | 0.5 | 0.0 | 0.1 | 0.2 | 1.2 | 1.1 |
| Malignant neoplasms of respiratory and intrathoracic organs (C30-C39) | 32 | 0 | 3 | 4 | 17 | 8 | 0.2 | 0.0 | 0.1 | 0.1 | 0.4 | 0.6 |
| Melanoma and other malignant neoplasms of skin (C43-C44) | 1 | 0 | 0 | 0 | 1 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Malignant neoplasms of male genital organs (C60-C63) | 6 | 0 | 0 | 1 | 2 | 3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
| Malignant neoplasms of urinary tract (C64-C68) | 6 | 0 | 0 | 1 | 2 | 3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
| Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72) | 1 | 0 | 0 | 0 | 0 | 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Malignant neoplasms of ill-defined, secondary and unspecified sites (C76-C80) | 3 | 0 | 0 | 0 | 3 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue (C81-C96) | 21 | 0 | 3 | 5 | 10 | 3 | 0.1 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 |
| Benign neoplasms (D10-D36) | 1 | 0 | 1 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Neoplasms of uncertain or unknown behaviour (D37-D48) | 19 | 0 | 5 | 5 | 5 | 4 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.3 |
| Mental and behavioural disorders (F00-F99) | 736 | 136 | 165 | 283 | 146 | 6 | 4.5 | 5.8 | 4.7 | 5.6 | 3.6 | 0.5 |
| Organic, including symptomatic, mental disorders (F00-F09) | 1 | 0 | 0 | 0 | 1 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Mental and behavioural disorders due to psychoactive substance use (F10-F19) | 8 | 2 | 1 | 4 | 1 | 0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 |
| Schizophrenia, schizotypal and delusional disorders (F20-F29) | 22 | 3 | 6 | 9 | 4 | 0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 |
| Mood [affective] disorders (F30-F39) | 510 | 80 | 112 | 200 | 115 | 3 | 3.1 | 3.4 | 3.2 | 3.9 | 2.8 | 0.2 |
| Neurotic, stress-related and somatoform disorders (F40-F48) | 183 | 49 | 45 | 62 | 24 | 3 | 1.1 | 2.1 | 1.3 | 1.2 | 0.6 | 0.2 |
| Behavioural syndromes associated with physiological disturbances and physical factors (F50-F59) | 1 | 1 | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Disorders of adult personality and behaviour (F60-F69) | 1 | 0 | 0 | 1 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Disorders of psychological development (F80-F89) | 2 | 1 | 0 | 1 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Unspecified mental disorder (F99-F99) | 8 | 0 | 1 | 6 | 1 | 0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
Categories were omitted when there was no case.
Incidence rate of sick-leave due to neoplasms or mental and behavioural disorders among women in the J-ECOH cohort, 2012–2013.
| ICD-10 chapters and blocks | Number of spells during 2 years | Incidence rate of sick-leave (new spells/1000 person-years) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | Age categories, years | Overall | Age categories, years | |||||||||
| 20–29 | 30–39 | 40–49 | 50–59 | 60–64 | 20–29 | 30–39 | 40–49 | 50–59 | 60–64 | |||
| Neoplasms (C00-D48) | 58 | 3 | 7 | 25 | 16 | 7 | 1.9 | 0.7 | 0.9 | 2.4 | 2.6 | 3.8 |
| Malignant neoplasms (C00-C97) | 34 | 2 | 2 | 11 | 15 | 4 | 1.1 | 0.4 | 0.3 | 1.1 | 2.4 | 2.2 |
| Malignant neoplasms of lip, oral cavity and pharynx (C00-C14) | 1 | 0 | 0 | 0 | 1 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 |
| Malignant neoplasms of digestive organs (C15-C26) | 8 | 0 | 1 | 2 | 3 | 2 | 0.3 | 0.0 | 0.1 | 0.2 | 0.5 | 1.1 |
| Malignant neoplasms of respiratory and intrathoracic organs (C30-C39) | 2 | 0 | 0 | 0 | 2 | 0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 |
| Malignant neoplasm of breast (C50-C50) | 10 | 0 | 0 | 4 | 5 | 1 | 0.3 | 0.0 | 0.0 | 0.4 | 0.8 | 0.5 |
| Malignant neoplasms of female genital organs (C51-C58) | 9 | 0 | 1 | 4 | 4 | 0 | 0.3 | 0.0 | 0.1 | 0.4 | 0.6 | 0.0 |
| Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue (C81-C96) | 4 | 2 | 0 | 1 | 0 | 1 | 0.1 | 0.4 | 0.0 | 0.1 | 0.0 | 0.5 |
| Benign neoplasms (D10-D36) | 8 | 0 | 3 | 5 | 0 | 0 | 0.3 | 0.0 | 0.4 | 0.5 | 0.0 | 0.0 |
| Neoplasms of uncertain or unknown behaviour (D37-D48) | 16 | 1 | 2 | 9 | 1 | 3 | 0.5 | 0.2 | 0.3 | 0.9 | 0.2 | 1.6 |
| Mental and behavioural disorders (F00-F99) | 101 | 30 | 29 | 35 | 7 | 0 | 3.3 | 6.5 | 3.8 | 3.4 | 1.1 | 0.0 |
| Schizophrenia, schizotypal and delusional disorders (F20-F29) | 5 | 1 | 3 | 1 | 0 | 0 | 0.2 | 0.2 | 0.4 | 0.1 | 0.0 | 0.0 |
| Mood [affective] disorders (F30-F39) | 54 | 18 | 18 | 12 | 6 | 0 | 1.8 | 3.9 | 2.4 | 1.2 | 1.0 | 0.0 |
| Neurotic, stress-related and somatoform disorders (F40-F48) | 39 | 11 | 8 | 20 | 0 | 0 | 1.3 | 2.4 | 1.1 | 1.9 | 0.0 | 0.0 |
| Behavioural syndromes associated with physiological disturbances and physical factors (F50-F59) | 2 | 0 | 0 | 1 | 1 | 0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 |
| Unspecified mental disorder (F99-F99) | 1 | 0 | 0 | 1 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
Categories were omitted when there was no case.